EVLO - Evelo Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development39,88519,9579,134
Selling General and Administrative18,2187,5743,891
Non Recurring---
Others---
Total Operating Expenses58,10327,53113,025
Operating Income or Loss-58,103-27,531-13,025
Income from Continuing Operations
Total Other Income/Expenses Net1,157-516-307
Earnings Before Interest and Taxes-58,103-27,531-13,025
Interest Expense-900-500-300
Income Before Tax-56,946-28,047-13,332
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-56,946-28,047-13,332
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-56,946-28,047-13,332
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-60,883-34,132-14,977